Amarin Corporation plc (NASDAQ:AMRN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
(b) Resignation of James Healy.
On December14, 2016, James I. Healy, M.D., Ph.D. informed the
Board of Directors of Amarin Corporation plc (the Company) of his
resignation from the Board of Directors, effective December20,
2016. Dr.Healys resignation was not caused by any disagreement
with the Company on any matter relating to the Companys
operations, policies or practices. A copy of Dr.Healys
resignation letter is attached as Exhibit 99.1 to this Current
Report on Form 8-K.
| Item9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits: |
|
Exhibit No. |
Description |
|
| 99.1 |
Resignation Letter of Dr.JamesI. Healy, dated December14, 2016 |
***
About Amarin Corporation plc (NASDAQ:AMRN)
Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company’s lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The Company operates in the business segment of development and commercialization of Vascepa. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its Distributors, that in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers. The Company markets Vascepa in the United States. Amarin Corporation plc (NASDAQ:AMRN) Recent Trading Information
Amarin Corporation plc (NASDAQ:AMRN) closed its last trading session down -0.04 at 3.16 with 1,996,980 shares trading hands.